Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 2Lymphoma, Follicular 1Lymphoma 1Leukemia 1Cognitive Dysfunction 1Brain Neoplasms 1Brain Injuries, Traumatic 1Attention Deficit Disorder with Hyperactivity 1Anxiety Disorders 1

Interventions

Filgrastim 4Magnetic Resonance Spectroscopy 3Dexamethasone 3entrectinib 2Vincristine 2Temozolomide 2Pemetrexed 2Methylphenidate 2Methods 2Drug Therapy 2Cytarabine 2Cyclophosphamide 2Carmustine 2trametinib 1sonidegib 1selinexor 1sargramostim 1ribociclib 1gadobutrol 1gadobenic acid 1entinostat 1cc-486 1carboxyamido-triazole 1alovudine 1alectinib 1Zidovudine 1Watchful Waiting 1WP 744 1Topotecan 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Control Groups × Lymphoid × Clear all
NCT00498719 2020-12-31

Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer

M.D. Anderson Cancer Center

Unknown
30 enrolled
CNSLymphoidOther hematologic neoplasm

Attention Deficit Disorder with Hyperactivity, Brain Neoplasms, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡